ArticleBMJ open2026
Healthcare professionals' understanding and current practice in sarcopenia screening and diagnosis in the UK: a qualitative study.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo explore healthcare professionals' (HCPs') understanding and current practice in the screening and diagnosis of sarcopenia to help with the development of a standardised sarcopenia screening tool that can be implemented within the National Health Service (NHS) of the UK.
designA qualitative study using semistructured interviews that were analysed using Braun and Clarke's reflexive thematic analysis steps.
settingThe interviews were conducted online.
participantsTen HCPs (consultants, physiotherapists, community matrons, dieticians and community falls specialists) within acute or community NHS settings based in the West Yorkshire area. No prior knowledge of sarcopenia was necessary.
resultsFive key themes were identified including (1) sarcopenia as an unseen condition; (2) current practice for sarcopenia screening; (3) challenges of measurement; (4) knowledge gaps and awareness and (5) patient trust and engagement. Interviews revealed a lack of consistency of sarcopenia awareness and understanding across HCPs, no formal screening of sarcopenia and several barriers including time constraints, resource limitations, lack of access to equipment and insufficient education on sarcopenia and its clinical consequences.
conclusionsThere is a need for a standardised screening tool to be implemented within NHS care pathways to allow for the early assessment and early management of sarcopenia. The future screening tool should embed a clear process of the measurements to be taken (including identifying which HCPs are responsible), defined management pathways for patients identified as sarcopenic, and integrated education for HCPs to promote cross-skilling of HCPs and alleviate pressures across the NHS system.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.